Loco-regional treatments on the liver transplant waiting list:unmasking hepatocellular carcinoma (HCC) biology
Hepatocellular carcinoma (HCC) is the sixth most prevalent cancer worldwide and is a leading cause of morbidity and mortality in patients with cirrhosis (1). Although it is the second most common indication for liver transplantation in Europe (2), the optimal management of patients awaiting liver transplantation is still not established (3).
7
Dr. Amine Benmassaoud is supported by the Canadian Association for the Study of Liver and Canadian Liver Foundation
2019-07-18(万方平台首次上网日期,不代表论文的发表时间)
共3页
199-201